Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.
udgivet i: Journal of Clinical Oncology
dato for udgivelse: 2015-01-20
sprog: engelsk
main subject: phase I clinical trial, Ferskvand
Cites articles
There is nothing here
Artikel - wd:Q33419897